CD46 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.780000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.869410E-01
Normal-vs-Stage2
3.464800E-01
Normal-vs-Stage3
4.957600E-01
Normal-vs-Stage4
2.280400E-01
Stage1-vs-Stage2
7.600200E-01
Stage1-vs-Stage3
7.121600E-02
Stage1-vs-Stage4
6.234200E-01
Stage2-vs-Stage3
8.006300E-02
Stage2-vs-Stage4
3.911000E-01
Stage3-vs-Stage4
1.101810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.021800E-01
Normal-vs-AfricanAmerican
8.204200E-02
Normal-vs-Asian
3.685800E-01
Caucasian-vs-AfricanAmerican
7.410000E-01
Caucasian-vs-Asian
5.579800E-01
AfricanAmerican-vs-Asian
9.254200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.294600E-01
Normal-vs-Female
4.463600E-01
Male-vs-Female
7.559500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.379800E-01
Normal-vs-Age(41-60Yrs)
2.039000E-01
Normal-vs-Age(61-80Yrs)
4.713600E-01
Normal-vs-Age(81-100Yrs)
5.841800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.952600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.221200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.267000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.265800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.830500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.189200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.286400E-01
Normal-vs-Daily Drinker
6.133400E-01
Normal-vs-Weekly Drinker
6.297600E-01
Normal-vs-Occasional Drinker
1.082590E-01
Normal-vs-Social Drinker
2.967200E-01
Non Drinker-vs-Daily Drinker
4.527600E-01
Non Drinker-vs-Weekly Drinker
8.936000E-01
Non Drinker-vs-Occasional Drinker
1.683540E-02
Non Drinker-vs-Social Drinker
9.846800E-01
Daily Drinker-vs-Weekly Drinker
7.248200E-01
Daily Drinker-vs-Occasional Drinker
4.838800E-03
Daily Drinker-vs-Social Drinker
4.773600E-01
Weekly Drinker-vs-Occasional Drinker
7.770000E-02
Weekly Drinker-vs-Social Drinker
9.172400E-01
Occasional Drinker-vs-Social Drinker
2.697700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.409800E-02
Normal-vs-Grade 2
4.179500E-03
Normal-vs-Grade 3
3.095300E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.072000E-01
Grade 1-vs-Grade 3
3.198600E-01
Grade 1-vs-Grade 4
4.409800E-02
Grade 2-vs-Grade 3
8.777500E-02
Grade 2-vs-Grade 4
4.179500E-03
Grade 3-vs-Grade 4
3.095300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.716600E-01
Normal-vs-NonDiabetic
3.315400E-01
Diabetic-vs-NonDiabetic
1.491010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.573800E-01
Normal-vs-NoPancreatitis
4.276600E-01
Pancreatitis-vs-NoPancreatitis
3.607200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.046400E-01
Normal-vs-N1
4.182000E-01
N0-vs-N1
2.395400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.942200E-02
Normal-vs-TP53-NonMutant
3.337000E-01
TP53-Mutant-vs-TP53-NonMutant
5.717800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
